Table 3.
Median of Detection and recognition thresholds in cancer patients in the second chemotherapy cycle and controls
| Threshold | Cases (μmol/ml) | Controls (μmol/ml) | p * | Mean rank differences (z) | p** |
|---|---|---|---|---|---|
| Sweet DT | 6.4 ± 4 | 4.4 ± 1.7 | 0.05 | 2.22 | 0.027 |
| Sweet RT | 8.9 ± 4 | 8.1 ± 5.8 | 0.58 | 0.98 | 0.325 |
| Bitter DT | 92 ± 5.7 | 89.3 ± 16 | 0.30 | 0.85 | 0.398 |
| Bitter RT | 100 ± 8 | 95 ± 7 | 0.04 | 0.63 | 0.527 |
| Umami DT | 1.1 ± 0.8 | 0.84 ± 0.6 | 0.19 | 0.04 | 0.96 |
| Umami RT | 2.1 ± 0.7 | 1.9 ± 0.7 | 0.3 | 0.10 | 0.919 |
μmol/ml = micromol/millimeter
*Mann-Whitney U test
** Wilcoxon Signed Ranks test